Emcure Pharmaceuticals Ltd.
EMCURE
Pozycja w akcjach
#4334
Emcure Pharmaceuticals Limited is committed to providing high-quality,... Emcure Pharmaceuticals Limited is committed to providing high-quality, cost-effective healthcare solutions to a global market. The company boasts a diverse product lineup spanning numerous medical fields, such as women's health (gynecology), anti-infectives, pain relief, nutritional supplements (vitamins, minerals, and nutrients), hematology, oncology, respiratory treatments, HIV antivirals, gastrointestinal remedies, anti-diabetics, neurological medications, and cardiovascular therapies. Notable brand names under their umbrella include Orofer XT, Tenectase, Pause, Metpure XL, Vylda, Vitanova, and Proxym. Founded in 1981, Emcure Pharmaceuticals Limited is headquartered in Pune, India.
Cena akcji
$18.81
Kapitalizacja rynkowa
$3.57B
Zmiana (1 dzień)
-3.13%
Zmiana (1 rok)
18.91%
Kraj
IN
Handel Emcure Pharmaceuticals Ltd. (EMCURE)
Kategoria
Healthcare
Historia ceny akcji dla Emcure Pharmaceuticals Ltd. (EMCURE)
Najwyższa cena zamknięcia: $20.40 dnia 2026-10-01
Najniższa cena zamknięcia: $15.91 dnia 2024-07-01
Najniższa cena zamknięcia: $15.91 dnia 2024-07-01
Historia cen akcji firmy Emcure Pharmaceuticals Ltd. od 2024 do 2026
Roczna wydajność ceny akcji
| Rok | Wydajność |
|---|---|
| 2026 (TTM) | 16.96% |
| 2025 | -4.84% |
| 2024 | 0.00% |
Cena akcji podobnych firm lub konkurencji
| Firma | Cena akcji | Zmiana 1r% | Kraj |
|---|---|---|---|
| $171.67 | - |
DE
|
|
| $163.90 | 22.57% |
DE
|
|
| $40.45 | 43.11% |
JP
|
|
| $225.90 | 31.92% |
CH
|
|
| $18.43 | -4.03% |
IN
|
